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v The role of radiotherapy in the management of patients with optic pathway glioma is controversial. In a 
series of patients with optic pathway glioma treated at The Hospital for Sick Children in Toronto, five children 
were encountered who developed moyamoya phenomenon after radiotherapy. A retrospective review of the 
medical records was undertaken in order to assess the relationship between optic pathway glioma, neurofibro-
matosis type I (NFL), radiation therapy, and moyamoya disease. 
Forty-seven patients with optic pathway glioma were operated on at The Hospital for Sick Children between 
1971 and 1990. The moyamoya phenomenon did not occur in any of the 19 patients not receiving radiotherapy. 
Among the 28 patients who received radiotherapy, five developed moyamoya disease (two of 23 without NFL 
and three of five with NFL). There was a statistically significant relationship between radiotherapy and 
moyamoya disease when the analysis was stratified according to the presence of NFL (Mantel-Haensel chi-
squared test 15.23, p < 0.0 I). The high incidence of moyamoya disease (three of five cases, or 60%) in patients 
with NFL who have undergone radiotherapy suggests a synergistic relationship that should be considered when 
formulating a treatment plan for NFL patients with optic pathway glioma. 
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OPTIC pathway gliomas in childhood are typically low-grade astrocytomas, which follow a highly unpredictable course. Some remain static and 
quiescent for many years, which led Hoyt and Bagdas-
sarian4 to regard them as hamartomas. Others, how-
ever, take an aggressive course, increase rapidly in size, 
and frequently lead to the death of the patient. This un-
predictability has led to a divergence of opinion about 
the management of these tumors. Some physicians ad-
vocate resection without any further therapy, others rec-
ommend radiation therapy or chemotherapy. and still 
others believe these tumors require no treatment. 8. I 1.11 
In the past, radiation therapy was the common mode 
of treatment for optic pathway glioma. As reports about 
the harmful effects and unsatisfactory results of this 
therapy emerged in the literature, other modalities 
gained prominence, Chief among these was chemo-
therapy, which has proven effective despite the benign 
nature of these tumors.8 Furthermore, direct surgery on 
these tumors is now feasible with good results. 12 
The potentially harmful effects of irradiation on the 
developing central nervous system have been well doc-
umented. 3 One of the common sequelae, especially in 
children, is postradiation vasculopathy of the moya-
moya type.9. 10 This has been particularly noted in pa-
tients irradiated for optic pathway glioma.6 About one-
third of patients with optic glioma are found to have 
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neurofibromatosis type I (NF I), which is itself associ-
ated with the moyamoya phenomenon. 2.5 It is possible 
that the effects of NFl and radiotherapy are additive, 
resulting in a high risk of moyamoya disease. In order 
to investigate this relationship we studied patients with 
histologically proven optic pathway astrocytomas. 
Clinical Material and Methods 
A retrospective review of the office and hospital 
records of patients with histologically confirmed optic 
pathway astrocytoma operated on between 1971 and 
1990 at The Hospital for Sick Children was performed. 
Patients without recent follow-up evaluation were con-
tacted by telephone. Data were entered on a desktop 
personal computer and analyzed with commercially 
available statistical software. Proportions were com-
pared with the chi-squared test, and means were com-
pared with a t-test for independent means. 
Results 
A total of 47 patients with optic pathway astrocytoma 
were identified, 44 of whom received their initial sur-
gery at The Hospital for Sick Children. Three patients 
underwent tumor surgery elsewhere and were subse-
quently referred to us. Twenty-six tumors involved the 
optic chiasm, 12 were centered primarily in the hypo-
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TABLE I 
SllInmarr o/paricn/s lrirli mO)W/lora plieIlOl»crWIl* 
Factor Case 1 Case 2 Case 3 Case 4 Case 5 
gender M F M M M 
neurofibromatosis-I no no yes yes yes 
age (yrs) 
at optic glioma diagnosis 3.8 1.6 1.3 3.0 4.4 
at radiotherapy 3.8 2.3 1.3 3.0 4.5 
radiation dose (rad) 5150 2500 5000 5000 5500 
moyamoya disease 
time to development (yrs) 1.8 7.2 3.3 3.1 3.0 
presentation seizures TIA's TIA's, then stroke stroke TIA's 
treatment none (anticonvul- rt EDAS ASA for TIA's, bilat bilat EDAS bilat EDAS 
sants for seizures) EDAS after stroke 
follow-up period 3.3 yrs 10 mos 1 yr 1.8 yrs 5.3 yrs 
follow-up findings progressive neuro- rt hemisphere TIA's 6 no further ischemic no further ischemic It hemisphere TIA's 
logical deteriora- wks postop. resol ved events events 11 mos postop. resolved 
tion to death aged on ASA on ASA 
8.9 yrs 
* TIA '" transient ischemic attack; EDAS = encephaloduroarteriosynangiosis; ASA = acetylsalicylic acid (aspirin) treatment. 
fIG. I. Case I. Lateral carotid arteriogram showing oc-
clusion of the tenninal internal carotid artery and extensive 
moyamoya vessels; this patient eventually died of moyamova 
disease. . 
thalamus, eight involved a single optic nerve, and one 
involved both optic nerves. Twenty-eight of the 47 
patients underwent radiotherapy at some point in their 
treatment. 
Of the 47 patients reviewed, five were found to have 
exhibited the moyamoya phenomenon at some time 
after tumor treatment (Table I). These five patients 
ranged in age from 1.3 to 4.4 years at the time of treat-
ment of their optic tumor (average age 2.8 years). They 
were all Caucasian; four were boys and one was a girL 
All five patients who developed moyamoya disease 
had received radiotherapy less than 6 months postop-
eratively. Four patients received 5000 rad or more and 
one patient received 2500 rad. At the time of radio-
therapy, patients ranged in age from l.3 to 4.5 years 
(mean 3.1 years). There was a mean interval of 3.7 
years between radiotherapy and the development of 
moyamoya disease. 
The presentation of moyamoya disease was ischemic 
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FIG. 2. Case 1. Cross section of the internal carotid artery 
at postmortem examination. Sclerotic changes in the vessels are 
evident. 
in four of the five cases, Two patients presented with 
transient ischemic attacks (TIA's), one presented with 
TIA's followed by a stroke, and the fourth initially suf-
fered a stroke. The fifth patient had a large chiasmatic 
glioma and was treated with biopsy and radiotherapy 
at 3 years of age. By 5 years of age he had suffered pro-
gressive neurological deterioration, with mental retar-
dation and seizures that were difficult to control. His 
workup for the seizures included an angiogram, which 
demonstrated marked moyamoya disease changes (Fig. 
I). He did not undergo a revascularization procedure 
and died at 8.9 years of age. Autopsy revealed advanced 
sclerotic changes in the vessels at the base of the brain 
(Fig. 2), and numerous scattered small vessels in the 
basal ganglia showing concentric hyaline thickening. 
In all five .cases there was bilateral involvement of 
the intracranial vessels; usually the anterior and middle 
cerebral arteries were involved. Three of the five pa-
tients with moyamoya disease in this series also had 
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FIG. 3. Case 2, an infant with a larg~ chiasmatic tumor. 
Left: Contrast-enhanced computerized tomography scan 
showing the tumor obstructing the third ventricle ~nd produc-
ing hydrocephalus. Righi: Right internal carotid ~rteriogram 
showing normal vasculature. The child was treated by tumor 
resection and radiotherapy (2500 rad). 
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NF I: however. none disclosed other risk factors for 
moyamoya disease. such as family history, sickle-cell 
disease. Down's syndrome. hypertension. or connec-
tive-tissue disorder. 7 
The treatment given to this group of patients was 
primarily surgical. Four patients underwent encephalo-
duroarteriosynangiosis, which was performed bilater-
ally in three patients and unilaterally in one (Figs. 3 
and 4). In three of these four patients, aspirin was also 
given. One patient had been taking aspirin prior to 
,evascularization surgery, but despite this he suffered a 
stroke and was then referred for the revascularization 
procedure. Two patients had TIA's within a few months 
after the revascularization procedure. which responded 
to aspirin therapy. The four surviving patients have 
now been followed for an average of 2.1 years. None 
of these four who underwent revascularization proce-
dures for moyamoya disease has subsequently devel-
oped a stroke. 
FIG. 4. Studies in Case 2 on presentation for moyamoya disease 7 years after tumor resection. Upper Left: 
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Magnetic resonance image showing normal optic apparatus. Upper Right: Right common carotid arteriogram 
obtained at the same time showing occlusion of the intracranial portion of the right internal carotid artery. 
Lower: Right external carotid angiograms. anteroposterior (left) and lateral (right) views, obtained following an 
encephaloduroarteriosynangiosis procedure showing good collateral flow to the middle cerebral artery. 
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In order to assess the role of radiation therapy in the 
development of moyamoya disease in our group of 47 
patients with optic pathway astrocytoma, we performed 
a stratified analysis according to the presence or absence 
of NFl (Table 2). Five patients who had undergone 
radiation therapy also had NF 1. Three (60%) of these 
patients developed moyamoya disease. There were 23 
patients who underwent radiotherapy but did not have 
neurofibromatosis. Two (9%) of these developed moya-
moya disease. Moyamoya disease did not occur in any 
of the 19 patients who were not irradiated (regardless 
of the presence or absence of neurofibromatosis). These 
proportions are significantly different (Mantel-Haensel 
chi-squared test 15.23. p < 0.01). 
Of the patients who developed moyamoya disease, 
the average age at the time of radiotherapy was 3 years, 
compared to 6 years in the patients who did not develop 
moyamoya disease. These mean ages are significantly 
different based on a t-test for independent means (t = 
2.26, p = 0.03). 
Discussion 
We have reviewed a group of 47 patients with optic 
pathway glioma and identified five who developed the 
moyamoya phenomenon. All five had undergone radi-
ation therapy prior to the age of 5 years. Moyamoya 
disease developed after an average interval of a little 
less than 4 years. These data suggest that there may be 
an association between radiotherapy and the develop-
ment of the moyamoya phenomenon even when the 
presence or absence of neurofibromatosis is accounted 
for. These findings are in agreement with those of Beyer, 
et al., I who found that patients with optic glioma and 
neurofibromatosis developed moyamoya disease after 
an average radiotherapy dose of 3927 rad, whereas 
patients with optic pathway glioma but without neuro-
fibromatosis developed moyamoya disease after an av-
erage radiotherapy dose of 5164 rad. Patients with 
neurofibromatosis appear to be more susceptible to 
radiation-induced vascular injury. Younger patients 
particularly appear to be more susceptible to postradia-
TABLE 2 
Incidence o!moyamoya phenomenon among 47 patients with 
optic pathway astrocytoma· 
Total Cases With Moyamoya Feature Cases No. Percent 
RT& NFl 5 3 60 
RT, no NFl 23 2 9 
no RT. NFl present 5 0 0 
no RT, no NFl 14 0 0 
• RT = radiotherapy; NF I = neurofibromatosis type I. Significance 
of difference: chi-squared test 15.23, p < om. 
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tion vascular injury.) The majority of patients reported 
as having postradiation moyamoya disease received 
radiotherapy in the first few years of life. I h'i III Patients 
who developed moyamoya disease in this series had a 
younger mean age (3 years) at the time of irradiation 
than those who did not develop moyamoya disease (6 
years). 
Conclusions 
The high incidence of moyamoya disease in patients 
with NFl who have undergone radiotherapy suggests a 
synergistic relationship that should be considered when 
a treatment plan is being formulated for patients with 
optic pathway glioma. This is particularly important 
when patients are younger than 5 years of age. 
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